HYAL2 and melanoma: T/B cell-deficient NOD-SCID mice received Hyal-2 or pY216-Hyal-2 antiserum via tail vein injections once per week for 3 consecutive weeks21,22, followed by resting for 2 weeks and then inoculating with mouse melanoma B16F10 cells.